Research concludes professional disease education leads to greater treatment adoptions.
Through its Veeva Pulse Field Trends Report, Veeva Systems has announced the findings of field medical's impact on clinical practice. According to the report’s analysis, disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption.
Reportedly, scientific engagement with KOLs provides an enduring impact on new treatment adoption. Despite this discovery, 70% only engage with one company's field medical team, leaving a need for better field planning and connected insights across organizations.
"The right data is foundational to our engagement strategy. We can quickly identify who the relevant KOLs are and organize those KOLs based on when and where they are sharing scientific information and what scientific information they are sharing," said Christine Castro, director of medical affairs excellence, Lundbeck, in a company press release. "As we prepared for the launch of new treatments, this data-driven approach helped us build the right relationships and focus our resources where they will have the greatest scientific impact."
Reference: Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption. PR Newswire. July 26, 2023. Accessed July 28, 2023. https://www.prnewswire.com/news-releases/veeva-pulse-uncovers-field-medical-engagement-drives-1-5x-increase-in-treatment-adoption-301885869.html
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.